Evidence map›Paper›PMID 40733703›Full record

ArticleVaccines2025

COVID-19 Vaccine Response in Allo-HSCT Recipients: Insights from a Real-World Prospective Cohort Study.

Emine Merve Savaş, Şeyma Yıldız, Zübeyde Nur Özkurt, Zehra Baltacı, Özlem Güzel Tunçcan, Zeynep Arzu Yeğin, Kayhan Çağlar, Nurdan Köktürk, Gonca Erbaş, Gülendam Bozdayı and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emine Merve SavaşDepartment of Hematology, Faculty of Medicine, Gazi University, Ankara 06560, Türkiye.
Şeyma YıldızDepartment of Hematology, Faculty of Medicine, Gazi University, Ankara 06560, Türkiye.
Zübeyde Nur ÖzkurtDepartment of Hematology, Faculty of Medicine, Gazi University, Ankara 06560, Türkiye.
Zehra BaltacıDepartment of Hematology, Faculty of Medicine, Gazi University, Ankara 06560, Türkiye.
Özlem Güzel TunçcanDepartment of Infectious Disease and Clinical Microbiology, Faculty of Medicine, Gazi University, Ankara 06560, Türkiye.
Zeynep Arzu YeğinDepartment of Hematology, Faculty of Medicine, Gazi University, Ankara 06560, Türkiye.
Kayhan ÇağlarDepartment of Medical Microbiology, Faculty of Medicine, Gazi University, Ankara 06560, Türkiye.ORCID 0000-0001-7257-6453
Nurdan KöktürkDepartment of Pulmonary Medicine, Faculty of Medicine, Gazi University, Ankara 06560, Türkiye.ORCID 0000-0002-2889-7265
Gonca ErbaşDepartment of Radiology, Faculty of Medicine, Gazi University, Ankara 06560, Türkiye.
Gülendam BozdayıDepartment of Medical Microbiology, Faculty of Medicine, Gazi University, Ankara 06560, Türkiye.
Münci YağcıDepartment of Hematology, Faculty of Medicine, Gazi University, Ankara 06560, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Allo-HSCTantibody responseCOVID-19 vaccinationimmunosuppression

Identifiers

PMID40733703
PMCPMC12299849

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.